Trial Profile
A Phase I, Open Label Study to Assess the Effects of PQ912 on the Pharmacokinetics of Midazolam and Omeprazole in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Varoglutamstat (Primary) ; Midazolam; Omeprazole
- Indications Alzheimer's disease; Huntington's disease; Inflammation
- Focus Pharmacokinetics
- Sponsors Probiodrug; Vivoryon Therapeutics
- 20 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 18 Jul 2014 New trial record